Penumbra, Inc. (PEN)
319.72
+0.28
(+0.09%)
USD |
NYSE |
Sep 24, 16:00
319.64
-0.08
(-0.03%)
Pre-Market: 19:59
Penumbra Gross Profit (Annual) : 921.65M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 921.65M |
| December 31, 2024 | 749.81M |
| December 31, 2023 | 672.69M |
| December 31, 2022 | 526.29M |
| December 31, 2021 | 472.76M |
| December 31, 2020 | 337.37M |
| December 31, 2019 | 371.18M |
| Date | Value |
|---|---|
| December 31, 2018 | 291.70M |
| December 31, 2017 | 216.72M |
| December 31, 2016 | 172.00M |
| December 31, 2015 | 124.81M |
| December 31, 2014 | 82.99M |
| December 31, 2013 | 57.98M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Boston Scientific Corp. | 13.06B |
| Teleflex, Inc. | 1.126B |
| Globus Medical, Inc. | 1.863B |
| Abbott Laboratories | 23.37B |
| AngioDynamics, Inc. | 164.21M |